Vaccine Lab / Alfa Chemistry
DODMA

Our customer services representatives are available 24 hours a day, from Monday to Sunday.

CONTACT US

DODMA

Catalog Number ACM104162472-2
CAS 104162-47-2
Structure
Description 1,2-dioleyloxy-3-dimethylaminopropane
Cationic lipids such as DODMA are considered non-viral carriers for gene therapy. DODMA is used for the preparation of cationic liposomes or lipid nanoparticles (LNP) needing a neutral or low zeta potential. DODMA is extremely effective at encapsulating nucleic acids due to its ability to temporarily reduce pH.
Synonyms 1,2-Dioleyloxy-3-dimethylamino-propane
IUPAC Name N,N-dimethyl-2,3-bis[(Z)-octadec-9-enoxy]propan-1-amine
Molecular Weight 620.1
Molecular Formula C41H81NO2
Canonical SMILES CCCCCCCC/C=C\CCCCCCCCOCC(CN(C)C)OCCCCCCCC/C=C\CCCCCCCC
InChI GLGLUQVVDHRLQK-WRBBJXAJSA-N
InChI Key InChI=1S/C41H81NO2/c1-5-7-9-11-13-15-17-19-21-23-25-27-29-31-33-35-37-43-40-41(39-42(3)4)44-38-36-34-32-30-28-26-24-22-20-18-16-14-12-10-8-6-2/h19-22,41H,5-18,23-40H2,1-4H3/b21-19-,22-20-
Boiling Point 649.7±55.0 °C(Predicted)
Purity >99%
Density 0.869±0.06 g/cm3(Predicted)
Appearance Colorless to light yellow liquid
Complexity 573
Covalently-Bonded Unit Count 1
Defined Atom Stereocenter Count 0
Exact Mass 619.63
Form Powder
Heavy Atom Count 44
Hydrogen Bond Acceptor Count 3
Hydrogen Bond Donor Count 0
Hygroscopic No
Isomeric SMILES CCCCCCCC/C=C\CCCCCCCCOCC(CN(C)C)OCCCCCCCC/C=C\CCCCCCCC
Light Sensitive No
Monoisotopic Mass 619.62673083
Percent Composition C 79.41% H 13.17% N 2.26% O 5.16%
Physical State Solid
Rotatable Bond Count 37
Shipping Ambient temperature
Stability 1 Year
Storage Conditions -20 °C
Storage Temperature -20℃
Topological Polar Surface Area 21.7 Ų
Knowledge & Learning Case Study Q&A

Common Cationic Lipids and Their Applications in Vaccines

Messenger RNA (mRNA) vaccines have emerged as a groundbreaking tool in the realm of vaccine development. Unlike traditional vaccines, mRNA vaccines work by introducing genetic material encoding a specific antigen into cells, prompting the cells to produce the antigen themselves. This approach stimulates an immune response as the body identifies the antigen as foreign and generates antibodies to combat it. One of the key benefits of mRNA vaccines is their agility in design and production, allowing for rapid response to emerging threats such as viral outbreaks or mutations. Get more information on:

  • Role of mRNA in Vaccine Development
  • Importance of Cationic Lipids in mRNA Delivery
  • Cationic Lipids in mRNA Vaccine Formulations
  • Popular Cationic Lipids from Alfa Chemistry
  • Examples of Cationic Lipids Utilized in Vaccines

Our products and services are for research use only and cannot be used for any clinical purposes.

Online Inquiry
Verification code